April 24, 2026 FDA Accelerates Review of Psychedelic Drugs for Mental Health with Priority Review Vouchers for Compass, Usona, and Transcend Therapeutics
April 23, 2026 Title: New Medicare Coverage Pathway Aims to Speed Access to Breakthrough Medical Devices
